While there may be a potential effect of ivermectin on viral clearance, it should not be sensationalized as a substitute for vaccines, and high-quality randomized trials are needed.

“I agree with Dr. Seheult that we should be studying these repurposed therapeutics. There is a potential for ivermectin. At least in my opinion at the very least, it seems as though it's pretty consistently involved in speeding up the viral clearance to some degree.”

Ivermectin should be studied in randomized controlled trials to determine its efficacy against COVID-19, but it is not a substitute for other layers of protection like vaccination.

“The point is, is that we should be looking at these medications. It should be done in a randomized controlled trial under a specific study platform, and we shouldn't be writing these things off.”